These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29162497)

  • 1. Expression signatures of early-stage and advanced medaka melanomas.
    Klotz B; Kneitz S; Regensburger M; Hahn L; Dannemann M; Kelso J; Nickel B; Lu Y; Boswell W; Postlethwait J; Warren W; Kunz M; Walter RB; Schartl M
    Comp Biochem Physiol C Toxicol Pharmacol; 2018 Jun; 208():20-28. PubMed ID: 29162497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutated EGFR is sufficient to induce malignant melanoma with genetic background-dependent histopathologies.
    Schartl M; Wilde B; Laisney JA; Taniguchi Y; Takeda S; Meierjohann S
    J Invest Dermatol; 2010 Jan; 130(1):249-58. PubMed ID: 19609310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
    Mishra RR; Kneitz S; Schartl M
    Comp Biochem Physiol C Toxicol Pharmacol; 2014 Jun; 163():64-76. PubMed ID: 24462553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole Body Melanoma Transcriptome Response in Medaka.
    Schartl M; Shen Y; Maurus K; Walter R; Tomlinson C; Wilson RK; Postlethwait J; Warren WC
    PLoS One; 2015; 10(12):e0143057. PubMed ID: 26714172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional background effects on a tumor driver gene in different pigment cell types of medaka.
    Abdulsahib S; Boswell W; Boswell M; Savage M; Schartl M; Lu Y
    J Exp Zool B Mol Dev Evol; 2024 May; 342(3):252-259. PubMed ID: 37877158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xmrk in medaka: a new genetic melanoma model.
    Patton EE; Nairn RS
    J Invest Dermatol; 2010 Jan; 130(1):14-7. PubMed ID: 20010863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression Signatures of Cisplatin- and Trametinib-Treated Early-Stage Medaka Melanomas.
    Klotz B; Kneitz S; Lu Y; Boswell W; Postlethwait J; Warren W; Walter RB; Schartl M
    G3 (Bethesda); 2019 Jul; 9(7):2267-2276. PubMed ID: 31101653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved expression signatures between medaka and human pigment cell tumors.
    Schartl M; Kneitz S; Wilde B; Wagner T; Henkel CV; Spaink HP; Meierjohann S
    PLoS One; 2012; 7(5):e37880. PubMed ID: 22693581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the Transcriptional Disease Signature (TDSs) to Screen Melanoma-Effective Compounds in a Small Fish Model.
    Lu Y; Boswell W; Boswell M; Klotz B; Kneitz S; Regneri J; Savage M; Mendoza C; Postlethwait J; Warren WC; Schartl M; Walter RB
    Sci Rep; 2019 Jan; 9(1):530. PubMed ID: 30679619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
    Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
    Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MITF-M plays an essential role in transcriptional activation and signal transduction in Xiphophorus melanoma.
    Delfgaauw J; Duschl J; Wellbrock C; Froschauer C; Schartl M; Altschmied J
    Gene; 2003 Nov; 320():117-26. PubMed ID: 14597395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathway activation features linked with transition from normal skin to primary and metastatic melanomas in human.
    Shepelin D; Korzinkin M; Vanyushina A; Aliper A; Borisov N; Vasilov R; Zhukov N; Sokov D; Prassolov V; Gaifullin N; Zhavoronkov A; Bhullar B; Buzdin A
    Oncotarget; 2016 Jan; 7(1):656-70. PubMed ID: 26624979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of transposable elements in the medaka melanoma model.
    Helmprobst F; Kneitz S; Klotz B; Naville M; Dechaud C; Volff JN; Schartl M
    PLoS One; 2021; 16(10):e0251713. PubMed ID: 34705830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.
    Travnickova J; Wojciechowska S; Khamseh A; Gautier P; Brown DV; Lefevre T; Brombin A; Ewing A; Capper A; Spitzer M; Dilshat R; Semple CA; Mathers ME; Lister JA; Steingrimsson E; Voet T; Ponting CP; Patton EE
    Cancer Res; 2019 Nov; 79(22):5769-5784. PubMed ID: 31582381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish.
    Dovey M; White RM; Zon LI
    Zebrafish; 2009 Dec; 6(4):397-404. PubMed ID: 19954345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes.
    Chiu KP; Ariyaratne P; Xu H; Tan A; Ng P; Liu ET; Ruan Y; Wei CL; Sung WK
    BMC Cancer; 2007 Jun; 7():109. PubMed ID: 17594473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signatures of microRNAs and selected microRNA target genes in human melanoma.
    Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
    Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generating and analyzing fish models of melanoma.
    Patton EE; Mathers ME; Schartl M
    Methods Cell Biol; 2011; 105():339-66. PubMed ID: 21951537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas.
    Kunz M; Löffler-Wirth H; Dannemann M; Willscher E; Doose G; Kelso J; Kottek T; Nickel B; Hopp L; Landsberg J; Hoffmann S; Tüting T; Zigrino P; Mauch C; Utikal J; Ziemer M; Schulze HJ; Hölzel M; Roesch A; Kneitz S; Meierjohann S; Bosserhoff A; Binder H; Schartl M
    Oncogene; 2018 Nov; 37(47):6136-6151. PubMed ID: 29995873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.
    Hoek K; Rimm DL; Williams KR; Zhao H; Ariyan S; Lin A; Kluger HM; Berger AJ; Cheng E; Trombetta ES; Wu T; Niinobe M; Yoshikawa K; Hannigan GE; Halaban R
    Cancer Res; 2004 Aug; 64(15):5270-82. PubMed ID: 15289333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.